Up a level |
Haider, Najmul, Rothman-Ostrow, Peregrine ORCID: 0000-0001-9711-751X, Osman, Abdinasir Yusuf, Arruda, Liã Bárbara, Macfarlane-Berry, Laura, Elton, Linzy, Thomason, Margaret J, Yeboah-Manu, Dorothy, Ansumana, Rashid, Kapata, Nathan et al (show 6 more authors)
(2020)
COVID-19—Zoonosis or Emerging Infectious Disease?
Frontiers in Public Health, 8.
596944-.
Hakim, James G, Thompson, Jennifer, Kityo, Cissy, Hoppe, Anne, Kambugu, Andrew, van Oosterhout, Joep J, Lugemwa, Abbas, Siika, Abraham, Mwebaze, Raymond, Mweemba, Aggrey et al (show 7 more authors)
(2017)
Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up results from a randomised controlled trial.
The Lancet. Infectious diseases, 18 (1).
pp. 47-57.